In brief glutamine exerts a major role in the cancer cells, by acting as a precursor for macromolecules and by maintaining the ATP supply through the Krebs cycle, mainly through GAC function activated by c-Myc and by increasing the proliferation by the inactivation of p53 which consequently attenuates GLS2 expression. This evidence concerns the gene MYC and cancer.